Non-opioid ‘pain sponge’ therapy shows promise for chronic pain relief and halting cartilage degeneration

SereNeuro Therapeutics, a preclinical biotechnology company developing non-opioid pain therapies, has unveiled new data on a novel approach to chronic pain management and joint tissue preservation. The data highlight SN101, a first-in-class induced pluripotent stem cell (iPSC)-derived therapy…
Read More

About The Author

Jonathan Jeriah

See author's posts